| Record no |
2019111845884 |
| Activity status |
Active |
| Working Title |
NITRITE REDUCTASE(NIRBD) AS NOVEL ANTI-TUBERCULAR DRUG TARGET |
| Working Inventors |
DHIMAN SARKAR; |
| Contributing institutions |
NCL |
| Administered by |
CSIR |
| Ownership |
|
| Categories > Subjects |
Biological sciences and engineering |
| Categories > Portfolio |
Fine chemical/pharma intermediate drugs/bioactives |
| Disclosure number |
2012-INV-0094 |
| NCL No |
2013-NCL-0010 |
| CSIR No |
2013-NF-0025
|
| Priority date |
02-27-2013 |
| Country |
GB |
| Application number |
13718409.9 |
| Provisional filing date |
|
| Complete filing date |
08-28-2015 |
| Publication status |
Yes |
| Publication date |
01-06-2016 |
| Publication no |
2961847 |
| Granted number |
2961847 |
| Granted date |
09-04-2019 |
| Final title |
NITRITE REDUCTASE(NIRBD) AS NOVEL ANTI-TUBERCULAR DRUG TARGET |
| Final Inventors |
DHIMAN SARKAR; |
| Abstract |
|
| Case status |
Granted + Inforce |
| Licensing status |
License(Licensing agreement)-Active |
| Licensing case no |
2015-LIC-00 |
| Client name |
ANNWESHAN SCITECH PVT. LTD |
| Lead inventors |
SARKAR DHIMAN |
| Categories > Industry > Primary |
Medical Biotechnology,Biomed Products,Medical/Healthcare |
| Categories > Industry > other |
|